Role of farnesoid X receptor and bile acids in alcoholic liver disease

被引:1
|
作者
Sharon Manley [1 ]
Wenxing Ding [1 ]
机构
[1] Department of Pharmacology, Toxicology and Therapeutics, the University of Kansas Medical Center
基金
美国国家卫生研究院;
关键词
Farnesoid X receptor; Bile acids; Autophagy; Alcoholic liver disease; FoxO3;
D O I
暂无
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
Alcoholic liver disease(ALD) is one of the major causes of liver morbidity and mortality worldwide. Chronic alcohol consumption leads to development of liver pathogenesis encompassing steatosis, inflammation, fibrosis, cirrhosis, and in extreme cases, hepatocellular carcinoma. Moreover,ALD may also associate with cholestasis. Emerging evidence now suggests that farnesoid X receptor(FXR) and bile acids also play important roles in ALD. In this review, we discuss the effects of alcohol consumption on FXR, bile acids and gut microbiome as well as their impacts on ALD. Moreover, we summarize the findings on FXR, Fox O3a(forkhead box-containing protein class O3a) and PPARα(peroxisome proliferator-activated receptor alpha) in regulation of autophagy-related gene transcription program and liver injury in response to alcohol exposure.
引用
收藏
页码:158 / 167
页数:10
相关论文
共 50 条
  • [11] Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease
    Xu, Jiao-Ya
    Li, Zhong-Ping
    Zhang, Li
    Ji, Guang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (37) : 13493 - 13500
  • [12] Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis
    Wu, Weibin
    Liu, Xijun
    Peng, Xiaomin
    Xue, Ruyi
    Ji, Lingling
    Shen, Xizhong
    Chen, She
    Gu, Jianxin
    Zhang, Si
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 448 (01) : 50 - 55
  • [13] Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease
    Kim, Sun-Gi
    Kim, Byung-Kwon
    Kim, Kyumin
    Fang, Sungsoon
    ENDOCRINOLOGY AND METABOLISM, 2016, 31 (04) : 500 - 504
  • [14] Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice
    Hartmann, Phillipp
    Hochrath, Katrin
    Horvath, Angela
    Chen, Peng
    Seebauer, Caroline T.
    Llorente, Cristina
    Wang, Lirui
    Alnouti, Yazen
    Fouts, Derrick E.
    Starkel, Peter
    Loomba, Rohit
    Coulter, Sally
    Liddle, Christopher
    Yu, Ruth T.
    Ling, Lei
    Rossi, Stephen J.
    DePaoli, Alex M.
    Downes, Michael
    Evans, Ronald M.
    Brenner, David A.
    Schnabl, Bernd
    HEPATOLOGY, 2018, 67 (06) : 2150 - 2166
  • [15] Farnesoid X Receptor-Mediated Bile Acids Regulation in Cholestasis
    Mohammed, Thamer Abdulla
    Zalzala, Munaf H.
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2024,
  • [16] Farnesoid X receptor,the bile acid sensing nuclear receptor,in liver regeneration
    Guodong Li
    Grace L.Guo
    Acta Pharmaceutica Sinica B, 2015, 5 (02) : 93 - 98
  • [17] Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
    Li, Guodong
    Guo, Grace L.
    ACTA PHARMACEUTICA SINICA B, 2015, 5 (02) : 93 - 98
  • [18] Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease
    Wu, Weibin
    Zhu, Bo
    Peng, Xiaomin
    Zhou, Meiling
    Jia, Dongwei
    Gu, Jianxin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 443 (01) : 68 - 73
  • [19] Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency
    Huang, Mingxing
    Kong, Bo
    Zhang, Min
    Rizzolo, Daniel
    Armstrong, Laura E.
    Schumacher, Justin D.
    Chow, Monica D.
    Lee, Yi-Horng
    Joseph, Laurie B.
    Stofan, Mary
    Zhang, Lanjing
    Guo, Grace L.
    LABORATORY INVESTIGATION, 2020, 100 (09) : 1158 - 1168
  • [20] Farnesoid X Receptor Agonists and Other Bile Acid Signaling Strategies for Treatment of Liver Disease
    Halilbasic, Emina
    Fuchs, Claudia
    Traussnigg, Stefan
    Trauner, Michael
    DIGESTIVE DISEASES, 2016, 34 (05) : 580 - 588